BRL 16.8
(-5.46%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 10.11 Billion BRL | 3.51% |
2022 | 9.76 Billion BRL | 31.89% |
2021 | 7.4 Billion BRL | 33.76% |
2020 | 5.53 Billion BRL | 292.58% |
2019 | 1.41 Billion BRL | 141.38% |
2018 | 584.3 Million BRL | -13.56% |
2017 | 675.98 Million BRL | -25.24% |
2016 | 904.2 Million BRL | -81.76% |
2015 | 4.95 Billion BRL | 1.87% |
2014 | 4.86 Billion BRL | 19.37% |
2013 | 4.07 Billion BRL | 0.0% |
2012 | - BRL | -100.0% |
2011 | 5.34 Billion BRL | 81.03% |
2010 | 2.95 Billion BRL | 32.87% |
2009 | 2.22 Billion BRL | 399.71% |
2008 | 444.36 Million BRL | -58.81% |
2007 | 1.07 Billion BRL | 469.73% |
2006 | 189.36 Million BRL | 45.22% |
2005 | 130.4 Million BRL | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 10.33 Billion BRL | -3.86% |
2024 Q1 | 10.74 Billion BRL | 6.29% |
2023 Q3 | 10.01 Billion BRL | 0.21% |
2023 FY | 10.11 Billion BRL | 3.51% |
2023 Q2 | 9.99 Billion BRL | 11.75% |
2023 Q1 | 8.94 Billion BRL | -8.43% |
2023 Q4 | 10.11 Billion BRL | 0.94% |
2022 FY | 9.68 Billion BRL | 31.89% |
2022 Q1 | 8.31 Billion BRL | 11.34% |
2022 Q3 | 8.96 Billion BRL | 10.01% |
2022 Q2 | 8.15 Billion BRL | -1.93% |
2022 Q4 | 9.76 Billion BRL | 8.94% |
2021 Q2 | 6.67 Billion BRL | -0.66% |
2021 Q3 | 7.5 Billion BRL | 12.38% |
2021 Q4 | 7.46 Billion BRL | -0.51% |
2021 FY | 7.4 Billion BRL | 33.76% |
2021 Q1 | 6.72 Billion BRL | 20.65% |
2020 FY | 5.59 Billion BRL | 292.58% |
2020 Q4 | 5.57 Billion BRL | -0.56% |
2020 Q1 | 2.06 Billion BRL | 44.17% |
2020 Q2 | 4.85 Billion BRL | 135.66% |
2020 Q3 | 5.6 Billion BRL | 15.27% |
2019 Q2 | 591.57 Million BRL | 2.61% |
2019 Q1 | 576.52 Million BRL | -1.33% |
2019 FY | 1.41 Billion BRL | 141.38% |
2019 Q4 | 1.43 Billion BRL | 149.96% |
2019 Q3 | 572.26 Million BRL | -3.26% |
2018 FY | 582.37 Million BRL | -13.56% |
2018 Q4 | 584.3 Million BRL | 9.06% |
2018 Q3 | 535.76 Million BRL | 20.0% |
2018 Q2 | 446.48 Million BRL | -12.34% |
2018 Q1 | 509.35 Million BRL | -24.65% |
2017 Q4 | 675.99 Million BRL | 2.7% |
2017 Q3 | 658.23 Million BRL | -0.87% |
2017 Q2 | 663.99 Million BRL | -25.25% |
2017 Q1 | 888.26 Million BRL | -1.76% |
2017 FY | 675.99 Million BRL | -25.24% |
2016 Q3 | 1.35 Billion BRL | -29.54% |
2016 FY | 907.56 Million BRL | -81.76% |
2016 Q4 | 904.2 Million BRL | -33.43% |
2016 Q2 | 1.92 Billion BRL | -11.88% |
2016 Q1 | 2.18 Billion BRL | -55.88% |
2015 Q2 | 5.02 Billion BRL | -1.67% |
2015 FY | 4.95 Billion BRL | 1.87% |
2015 Q4 | 4.95 Billion BRL | -9.51% |
2015 Q3 | 5.47 Billion BRL | 9.01% |
2015 Q1 | 5.11 Billion BRL | 5.02% |
2014 Q4 | 4.86 Billion BRL | 3.41% |
2014 Q3 | 4.7 Billion BRL | 5.67% |
2014 Q2 | 4.45 Billion BRL | 3.55% |
2014 FY | 4.86 Billion BRL | 19.37% |
2014 Q1 | 4.3 Billion BRL | 5.5% |
2013 Q1 | 4.42 Billion BRL | 0.0% |
2013 Q2 | 4.55 Billion BRL | 2.85% |
2013 Q3 | 4.96 Billion BRL | 9.03% |
2013 Q4 | 4.07 Billion BRL | -17.88% |
2013 FY | 4.07 Billion BRL | 0.0% |
2012 Q4 | - BRL | -100.0% |
2012 Q1 | 4.26 Billion BRL | -20.18% |
2012 Q2 | 4.42 Billion BRL | 3.8% |
2012 Q3 | 4.69 Billion BRL | 6.19% |
2012 FY | 4.43 Billion BRL | -100.0% |
2011 Q1 | 4.07 Billion BRL | 38.05% |
2011 Q3 | 5.11 Billion BRL | 3.08% |
2011 Q2 | 4.96 Billion BRL | 21.89% |
2011 Q4 | 5.34 Billion BRL | 4.38% |
2011 FY | 5.34 Billion BRL | 81.03% |
2010 Q3 | 3.33 Billion BRL | 35.4% |
2010 FY | 2.95 Billion BRL | 32.87% |
2010 Q2 | 2.46 Billion BRL | 38.28% |
2010 Q4 | 2.95 Billion BRL | -11.62% |
2010 Q1 | 1.78 Billion BRL | -19.71% |
2009 Q4 | 2.22 Billion BRL | 0.0% |
2009 FY | 2.22 Billion BRL | 399.71% |
2008 FY | 444.36 Million BRL | -58.81% |
2007 FY | 1.07 Billion BRL | 469.73% |
2006 FY | 189.36 Million BRL | 45.22% |
2005 FY | 130.4 Million BRL | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Blau FarmacĂȘutica S.A. | 603.73 Million BRL | -1574.768% |